Dr. Schminke: Comprehensive Notes on Menopause and Perimenopause

Annual Prevalence: In the United States, approximately $2 \times 10^6$ women reach menopause every year.
Mean Age of Onset: The average age for natural menopause in North America is approximately $52$ years old.
Lifespan Considerations: Due to increasing life expectancy, many women will live approximately one-third of their total lives in the postmenopausal stage.

Menopause (General Definition): This is characterized by the cessation of menses or uterine bleeding for a duration of $12$ consecutive months. * The "Clock" Rule: Any occurrence of bleeding during this period resets the $12$ -month clock. * Diagnostic Criteria: Laboratory tests are not required to confirm the diagnosis; it is a retrospective clinical diagnosis. * Median Age: The median age of onset in the U.S. is $52$ years old.
Perimenopause: This transitional phase typically occurs $2$ to $8$ years before the final menstrual period (Last Menses). * Duration: Generally lasts about $5$ years.
Early Postmenopause: Defined as the first $6$ years immediately following menopause. * Characteristics: This is a period marked by rapid bone loss and the prevalence of vasomotor symptoms.
Late Postmenopause: Defined as the period $6$ years from the onset of menopause and beyond. * Characteristics: This stage is marked by a more dramatic drop in estrogen levels, leading to increased genitourinary symptoms and elevated cardiovascular (CV) risks.

Physiological Mechanisms: * A primary feature is that the woman may not ovulate. * Cycles become increasingly irregular. * Estrogen levels fluctuate significantly. * The vascular system experiences cycles of vasoconstriction and vasodilation.
Clinical Presentation (What it Looks/Feels Like): * Risk Factors: Increased risk for Urinary Tract Infections (UTIs). * Somatic Complaints: Breast pain and joint pain. * Neurological Impacts: Menstrual migraines.

Retrospective Diagnosis: The diagnosis of menopause is made looking backward, as it is based on the absence of menses for $12$ consecutive months.
Hormonal Diagnostics: Serum FSH (Follicle-Stimulating Hormone) testing is no longer utilized for the primary diagnosis of menopause.
STRAW Staging: The "Stages of Reproductive Aging Workshop" (STRAW) proposed a staging system based on specific bleeding criteria to indicate the late menopausal transition.
Anti-Müllerian Hormone (AMH): AMH reflects the number of remaining follicles and may be utilized to identify current menopause status.
Symptomatic Overlap: Perimenopause includes many symptoms typically associated with menopause, such as hot flashes and vaginal dryness.

Central Nervous System (CNS): Clinical findings include sleep disturbances, depression, and "mental fog."
Vagina, Bladder, and Pelvic Floor: Issues include dryness, infection, stress incontinence, and pelvic organ prolapse.
Cardiovascular System: Increased risk for Myocardial Infarction (M.I.), stroke, and Coronary Artery Disease (CAD).
Bone Mass: Significant risk for osteoporosis and bone fractures.

Psychosocial Issues: Midlife is often characterized by children leaving the home, the illness or death of parents, and significant career changes.
Life Transitions: * Adjusting to concepts of personal mortality. * Adapting to shifts in family relationships. * The process of becoming "authentic." * Assessing and appreciating individual life experiences.
Psychological Growth: This life stage possesses significant potential for psychological development. Physical changes can often lead to a healthful shift toward self-focus.

Primary Risks: Menopausal and postmenopausal women face increased risks for: * Overweight and obesity. * Cardiovascular Disease (CVD). * Diabetes mellitus. * Cancer. * Osteoporosis. * Thyroid disease. * Depression.
Nursing Education focus: Education must prioritize prevention, lifestyle modification, and specific treatments modified for older adults.

Definition: Vasomotor symptoms primarily refer to hot flashes and night sweats.
Nonpharmacologic Management (1 of 2): * Dietary changes. * Exercise. * Vitamins and supplements.
Nonpharmacologic Management (2 of 2): * Clothing and environment (e.g., layering, cooler temperatures). * Smoking cessation. * Stress management. * Sleep hygiene. * Mental and cognitive stimulation. * Acupuncture (noted as effective for some women).
Pharmacologic Management (Hormone Therapy/HT): * Resolution: VMS usually begin to resolve within $2$ to $6$ weeks after medical initiation of Hormone Therapy (HT). * Requirement for Uterus: If the woman still has a uterus, she must be prescribed both Estrogen and Progesterone (to protect against endometrial hyperplasia). * Recurrence: If therapy is discontinued, there is a $50\%$ chance that symptoms will recur.

Etiology: Caused specifically by a lack of estrogen.
Prevalence: Nearly $85\%$ of women experience some degree of GSM by year $6$ post-menopause.
Symptom Classification: * Genital Symptoms: Dryness, burning sensation, and irritation. * Sexual Symptoms: Lack of lubrication, discomfort or pain during intercourse, and generally impaired function. * Urinary Symptoms: Urgency, dysuria (painful urination), and recurrent UTIs.
Management Strategies: * Vaginal lubricants and moisturizers specifically to relieve dryness. * Pessaries to manage bladder leakage. * Hormone therapy. * Laser treatment options.
Vaginal Atrophy Clinical Presentation: * Thinning of pubic hair. * Narrowing of the vaginal introitus. * Petechiae of vaginal tissues. * Loss of rugae (the folds in the vaginal wall).

Mechanism: Bone loss is directly linked to the decrease in estrogen levels.
Clinical Indicators: * Bone fractures. * Loss of height. * Receding gums. * Lower back pain. * "Humped back" (kyphosis).
Statistic: During the first $5$ years after menopause, women may lose an average of $10\%$ of their bone mass per year.
Treatments: * Weight-bearing exercises. * Medications: Biphosphonates are the most commonly prescribed class.

Leading Cause of Death: CVD remains the primary cause of mortality for women in the United States.
Metabolic Shift: The decrease in estrogen during menopause changes lipid metabolism.
Mitigation: Healthy diet and exercise are critical to offsetting risk.
Known Risk Factors: * Cigarette smoking. * Obesity. * Hypertension (High Blood Pressure). * Diabetes mellitus. * Hypercholesterolemia. * Family history of CV disease.

Common Patient Complaints: Hot flashes, vaginal dryness/GSM, and anxiety.
Professional Nursing Care Considerations: * Disturbed Sleep Pattern: Resulting from night sweats or CNS changes. * Risk for Injury: Related to bone loss/osteoporosis. * Sexual Dysfunction: Related to GSM and atrophy. * Stress Urinary Incontinence: Related to pelvic floor weakening. * Risk for Infection: Specifically recurrent UTIs. * Situational Low Self-Esteem: Related to midlife transitions and physical changes.